Download Blood Borne Pathogen Annual Training

Meadowlands Hospital Medical Center
Bloodborne
Pathogens
2
Learning Objectives
 Describe the epidemiology, symptoms, and infection risks of
select bloodborne pathogens.
 Recognize potentially infectious material, tasks with
occupational exposure, hazards, and exposure incidents.
 Employ controls—including engineering controls, work
practices, labeling, and personal protective equipment (PPE).
 Summarize components of postexposure management.
2014 ECRI Institute
3
OSHA’s Bloodborne Pathogens Standard
Exposure
determination
Exposure control
plan
Training
Labels and signs
Standard
precautions
Engineering and
work-practice
controls
Disposal of sharps
and regulated
medical waste,
cleaning, laundry
PPE
Hepatitis B virus
(HBV) vaccination
Postexposure
evaluation and
follow-up
Record keeping
Requirements for
HIV, HBV research
laboratories and
production facilities
2014 ECRI Institute
4
HIV
Hepatitis B, C, D
Syphilis
Creutzfeldt-Jakob disease
Bloodborne Pathogens: What Are They?
“Pathogenic microorganisms that are present in human blood and can cause
disease in humans”
Sources: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR
§ 1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS;
University of the Sciences. Q&A on OSHA’s bloodborne pathogens standard [online]. [cited 2014 May 13].
http://www.usciences.edu/safety/infotrain/qablood.htm
2014 ECRI Institute
5
HIV Infection: Stages
Early stage
• Many but not all
get symptoms
• May feel like
"worst flu ever"
• 2–4 weeks after
exposure
• Lasts a few days
to several weeks
Clinical latency
stage
Progression to AIDS
• No or mild
symptoms
• Often lasts a
decade in the
untreated
• Lasts longer in
treated patients
Sources: Centers for Disease Control and Prevention. About HIV/AIDS [online]. 2014 Feb 12 [cited 2014
May 13]. http://www.cdc.gov/hiv/basics/whatishiv.html; U.S. Department of Health and Human Services (U.S.
HHS); HIV/AIDS 101: signs and symptoms [online]. 2013 Dec 19 [cited 2014 May 13]. http://aids.gov/hivaids-basics/hiv-aids-101/signs-and-symptoms; U.S. HHS. Stages of HIV infection [online]. 2013 Dec 19
[cited 2014 May 13]. http://aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/hiv-in-your-body/stages-ofhiv
• Potential for
opportunistic
infections,
related cancers
• Treatment may
prevent
progression to
AIDS
2014 ECRI Institute
6
HIV Infection: Signs and Symptoms
Early stage
•
•
•
•
•
•
•
Fever
Swollen glands
Sore throat
Rash
Fatigue
Muscle, joint aches
Headache
Clinical latency stage
Progression to AIDS
• No or mild symptoms
Sources: Centers for Disease Control and Prevention. About HIV/AIDS [online]. 2014 Feb 12 [cited 2014
May 13]. http://www.cdc.gov/hiv/basics/whatishiv.html; U.S. Department of Health and Human Services (U.S.
HHS); HIV/AIDS 101: signs and symptoms [online]. 2013 Dec 19 [cited 2014 May 13]. http://aids.gov/hivaids-basics/hiv-aids-101/signs-and-symptoms; U.S. HHS. Stages of HIV infection [online]. 2013 Dec 19
[cited 2014 May 13]. http://aids.gov/hiv-aids-basics/just-diagnosed-with-hiv-aids/hiv-in-your-body/stages-ofhiv
•
•
•
•
•
•
Rapid weight loss
Fever, night sweats
Extreme tiredness
Lymph gland swelling
Long-lasting diarrhea
Oral, anal, genital
sores
• Pneumonia
• Blotches on skin,
mucous membranes
• Memory loss,
depression, etc.
2014 ECRI Institute
7
HBV Infection: Stages, Signs, and Symptoms
Acute infection
• 70% of adults get
symptoms
• Symptoms can
appear 6 weeks to 6
months after
exposure
• Symptoms usually
last a few weeks but
can last as long as 6
months
Chronic infection
•
•
•
•
•
•
•
•
Fever
Fatigue
Loss of appetite
Nausea
Vomiting
Abdominal pain
Dark urine
Clay-colored bowel
movements
• Joint pain
• Jaundice
• Most have no
symptoms for
decades
• Some have
symptoms like those
of acute infection
• 15%–25% get serious
liver conditions
• Some have no
symptoms even as
liver becomes
diseased
Source: Centers for Disease Control and Prevention. Hepatitis B FAQs for the public [online]. 2009 Jun 9
[cited 2014 May 13]. http://www.cdc.gov/hepatitis/b/bfaq.htm
2014 ECRI Institute
8
HCV Infection: Stages, Signs, and Symptoms
Acute infection
• 20%–30% of
people get
symptoms
• Symptoms can
appear 2 weeks
to 6 months after
exposure
Chronic infection
•
•
•
•
•
•
•
•
Fever
Fatigue
Loss of appetite
Nausea
Vomiting
Abdominal pain
Dark urine
Clay-colored bowel
movements
• Joint pain
• Jaundice
• Most have no
symptoms
• In many cases, no
symptoms until
liver problems
have developed
• Can lead to liver
damage, liver
failure, liver
cancer, even
death
Source: Centers for Disease Control and Prevention. Hepatitis C FAQs for the public [online]. 2014 Feb 10
[cited 2014 May 13]. http://www.cdc.gov/hepatitis/c/cfaq.htm
2014 ECRI Institute
9
1.4 million
800,000 to . . .
1.1 million
3.2 million
How Common Are Bloodborne Pathogens in
the United States?
* Age 13 or older
Sources: Centers for Disease Control and Prevention (CDC). HIV in the United States: at a glance [online].
2013 Dec 3 [cited 2014 May 13]. http://www.cdc.gov/hiv/statistics/basics/ataglance.html; CDC. Hepatitis B
FAQs for the public [online]. 2009 Jun 9 [cited 2014 May 13]. http://www.cdc.gov/hepatitis/b/bfaq.htm; CDC.
Hepatitis C FAQs for the public [online]. 2014 Feb 10 [cited 2014 May 13].
http://www.cdc.gov/hepatitis/c/cfaq.htm
2014 ECRI Institute
10
Standard Precautions: Approach All Blood
and OPIM As If They Were Infectious
16% of people with HIV
infection are unaware
of their infection.
19% of people with HIV
infection are age 55 or
older.
1965
1945
OPIM = other potentially infectious material
Sources: Centers for Disease Control and Prevention (CDC). HIV in the United States: at a glance [online].
2013 Dec 3 [cited 2014 May 13]. http://www.cdc.gov/hiv/statistics/basics/ataglance.html; CDC. HIV among
older Americans [online]. 2013 Dec 20 [cited 2014 May 13].
http://www.cdc.gov/hiv/risk/age/olderamericans/index.html; CDC. Hepatitis C FAQs for the public [online].
2014 Feb 10 [cited 2014 May 13]. http://www.cdc.gov/hepatitis/c/cfaq.htm.
2014 ECRI Institute
Chronic HCV
infection is
most
prevalent
among baby
boomers.
11
Who May Have Occupational Risk?
Anyone who works in healthcare and has
potential for exposure to infectious materials
 Infectious
body substances
 Contaminated medical supplies and equipment
 Contaminated surfaces
Source: Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the
management of occupational exposures to human immunodeficiency virus and recommendations for
postexposure prophylaxis. Infect Control Hosp Epidemiol 2013 Sep;34(9):875-92. Also available at
http://www.jstor.org/stable/10.1086/672271
2014 ECRI Institute
12
Blood and OPIM
Potentially infectious
Blood
Semen*
Body fluids with visible blood
Vaginal secretions*
All body fluids in situations in
which it is difficult or
impossible to differentiate
between body fluids
Cerebrospinal fluid
Synovial fluid
Pleural fluid
Peritoneal fluid
Pericardial fluid
Amniotic fluid
Unfixed human tissue or organ
(except skin)
HIV-containing cell, tissue, or
organ cultures
HIV- or HBV-containing culture
media or other solutions
Blood, organs, other tissues
from experimental animals
infected with HIV or HBV
Saliva (dental procedures)
* Potentially infectious but not implicated in occupational transmission
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
13
What Incidents Should Be Evaluated?
Contact between
potentially infectious
body fluid and
mucous membrane
or nonintact skin
Direct contact with
concentrated virus in
a research laboratory
Injury that pierces
the skin (e.g.,
needlestick, cut with
a sharp object)
Human bite
Evaluation
Source: Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the
management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure
prophylaxis. MMWR Recomm Rep 2001 Jun 29;50(RR-11):1-52. Also available at
http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
2014 ECRI Institute
14
Sharps: Not Just Needles
A contaminated sharp is “any contaminated
object that can penetrate the skin.”
“Contaminated” means “the presence or
the reasonably anticipated presence of
blood or other potentially infectious
materials on an item or surface.”
These are only examples.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
15
How Common Are Injuries?
 Each year, almost one in five healthcare workers experiences a
needlestick injury.
Your health and safety are important!
 Only 54% of injuries are reported.
Sources: Premier Safety Institute. Prevent needlestick injuries [online]. 2011 [cited 2014 May 14].
https://www.premierinc.com/quality-safety/toolsservices/safety/topics/needlestick/downloads/SharpsBRO_SEPT-2011-HR.pdf; Schillie S, Murphy TV,
Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for
administering postexposure management. MMWR Recomm Rep 2013 Dec 20;62(RR-10):1-19. Also
available at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6210a1.htm
2014 ECRI Institute
16
Likelihood of Getting Infected from
Percutaneous Exposure to Infected Blood
HIV
1 in 333
HBV (if unvaccinated)
HBeAg+
HBeAg-
HCV
1 in 4
1 in 100 - 1 in 17
1 in 56
Source: Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the
management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure
prophylaxis. MMWR Recomm Rep 2001 Jun 29;50(RR-11):1-52. Also available at
http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
2014 ECRI Institute
17
Documented Cases of HIV
Transmission to Healthcare
Personnel
CDC investigates voluntarily reported
cases of HIV transmission to healthcare
personnel. Cases may be underreported.
CDC analyzes cases in those with no
nonoccupational risk factors, but over 90%
of HIV-infected healthcare personnel have
nonoccupational risk factors.
From 1981 to 2010, CDC identified only 57
cases of documented HIV seroconversion
after occupational exposure.
Another 143 cases were identified as
“possible” cases of transmission.
Source: Centers for Disease Control and Prevention. Surveillance of occupationally acquired HIV/AIDS in
healthcare personnel, as of December 2010 [online]. 2011 May 23 [cited 2014 May 15].
http://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html
2014 ECRI Institute
18
Get Involved
OSHA requires
employers to
ask . . .
nonmanagerial
employees . . .
for input
regarding . . .
• responsible for
direct patient care
• who are potentially
exposed to injuries
from contaminated
sharps . . .
• identification,
• evaluation, and
• selection of
engineering and
work-practice
controls.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
19
Our Exposure Control Plan
 Our exposure control plan . . .
Is required by OSHA’s
bloodborne pathogens
standard
Describes how we implement
Engineering controls
Work-practice controls
PPE
Housekeeping
Sharps disposal
HBV vaccination
Biohazard labels
Training
Describes how exposure
incidents will be evaluated
Outlines what records we
keep regarding your
occupational exposure
 Our plan is located on our intranet in the Policy and Procedure Manual.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
20
HBV Vaccination: Efficacy and Dosing
Costs you nothing
 See employee
health nurse
Can prevent HBV infection
and serious consequences
Offers long-term
protection, possibly lifelong
Usual dosing schedule
1st 2nd
4 weeks
after 1st
dose
3rd
5 months
after 2nd
dose
Blood testing for immunity 1–2 months
after last dose
More vaccine doses and testing are
indicated if not immune
Source: Centers for Disease Control and Prevention. Hepatitis B vaccine: what you need to know [online].
2012 Feb 2 [cited 2014 May 16]. http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hep-b.pdf
2014 ECRI Institute
22
HBV Vaccination: Safety
HBV vaccine cannot cause
HBV infection.
Most people have no
problems.
Mild Problems
Injection site soreness
Up to 1 in 4 people
Fever
Up to 1 in 15 people
Severe Problems
Severe allergic
reaction
Source: Centers for Disease Control and Prevention. Hepatitis B vaccine: what you need to know [online].
2012 Feb 2 [cited 2014 May 16]. http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hep-b.pdf
2014 ECRI Institute
1 in 1.1 million
doses
23
Elimination and Substitution
 Elimination or substitution may be used only when clinically
appropriate.
 Examples are:
Oral rather than intravenous administration
 Use of a needleless device (e.g., needleless IV system)

2014 ECRI Institute
24
Engineering Controls: Sharps with
Engineered Sharps Injury Protections
 Intended to reduce the risk of a sharps injury
 Must be used appropriately to reduce injury risk
 We have the Vanish pint needle system (the needle retracts
directly from the skin)
2014 ECRI Institute
25
Engineering Controls: How We Select
Protective Devices
By seeking input from
direct care staff
 Determine availability
of
devices for applications that
pose exposure risk
 Review available devices at
least annually, including
changes in technology
Some factors to consider
•
•
•
•
•
•
•
User’s hands always behind needle
Integration of safety features
Ease of use
Use by right- and left-handed staff
Obvious engagement of safety feature
Locking of safety feature after activation
Safety feature activation before removal from
patient
• One-handed activation
• Permanent protection after activation
• Standardization issues
Sources: Occupational Safety and Health Administration (OSHA). Bloodborne pathogens [standard online].
29 CFR § 1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS; ECRI
Institute. Needlestick-prevention devices. Disposable syringes and injection needles. Health Devices 2007
Aug;36(8):241-73; ECRI Institute. Sharps safety and needlestick prevention. 2nd ed. Plymouth Meeting (PA):
ECRI Institute; 2003; Premier Safety Institute. Prevent needlestick injuries [online]. 2011 [cited 2014 May
14]. https://www.premierinc.com/quality-safety/tools-
2014 ECRI Institute
26
Engineering Controls: Use of Sharps
Disposal Containers
Discard sharps
immediately or as soon as
feasible.
Place reusable sharps in
appropriate containers
until reprocessed.
 If reprocessing,
don’t reach
by hand into the container.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
27
Engineering Controls: Replacement of
Sharps Disposal Containers
Don’t overfill.
Replace routinely.
When moving containers
of used sharps:
 Close
immediately before
removal.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
28
Containers for Disposal of Other
Regulated Waste
 Use appropriate containers.
 Close before removal.
 If outside of container is contaminated, place in second
container.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
29
Some Other Times to Clean and Disinfect
Disinfect . . .
• Contaminated work
surfaces
After
procedures
• Overtly contaminated
surfaces
• Blood or OPIM spills
Immediately
or as soon as
feasible
• Surfaces that may have
become decontaminated
since last cleaning
At end of shift
Replace equipment or
surface coverings:
 As soon
as feasible if
overtly contaminated
 At end of shift if they may
have become contaminated
during the shift
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
30
Contaminated Laundry
 Minimize agitation when handling.
 If wet and reasonably likely to soak or leak through the bag or
container, place in bag or container that prevents soak-through
and leakage.
 Wear gloves and other appropriate PPE.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
31
Ask for help
if patient is uncooperative.
Ensure stable surface
and available sharps container.
Limit butterfly use
use safety ones if necessary.
Don’t pass by hand
set sharp down and pick it up.
Use neutral zone
for minor non-OR surgeries.
Avoid recapping
use one-hand technique if required.
Dispose of sharps
immediately after use.
Clean broken glass
using brush and dustpan.
Inform other personnel
if patient is uncooperative.
Administrative Controls: Work Practices
Source: Premier Safety Institute. Safer work practices to prevent sharps injuries [online]. [cited 2013 Dec 5].
https://www.premierinc.com/needlestick/downloads/16_workpractices.doc
2014 ECRI Institute
32
Administrative Controls:
Signs and Labels
 Things that contain blood or OPIM are
labeled with this symbol.
 There are exceptions. For example,
the following may also contain blood
or OPIM:
Red bags, red containers
 Containers of blood or blood products
released for clinical use
 Individual containers placed in a labeled
container for storage, transport, disposal

Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
33
PPE: Types and Locations
 PPE is available at no cost to you.
 Located on each unit isolation carts
2014 ECRI Institute
34
PPE for Standard Precautions
• Hand contact with blood, OPIM,
mucous membranes, or nonintact
skin can be reasonably anticipated.
• You’re performing vascular access
procedures.
• You’re touching contaminated
items or surfaces.
• Gross contamination can be
reasonably anticipated.
Gloves
Masks
and eye
protection
Head
and/or
foot
protection
Protective
body
clothing
• Splashes, spray, spatter, or
droplets of blood or OPIM may be
generated AND
• eye, nose, or mouth contamination
can be reasonably anticipated.
• The task and degree of exposure
warrant.
 Also wear PPE as indicated by transmission-based precautions.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
35
1. Gown
PPE: Donning
See the complete sequence with detailed
steps on the Centers for Disease Control
and Prevention’s (CDC) website.
2. Mask or
respirator
3. Goggles
or face
shield
4. Gloves
Source: Centers for Disease Control and Prevention. Sequence for donning and removing personal
protective equipment [poster online]. [cited 2014 May 23].
http://www.cdc.gov/HAI/pdfs/ppe/ppeposter1322.pdf
2014 ECRI Institute
36
PPE: Safe Glove Use
 Replace disposable gloves:
As soon as practical if contaminated
 As soon as feasible if their ability to serve as a barrier is compromised
(e.g., they are torn or punctured)

 Don’t reuse disposable gloves.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
37
1. Gloves
PPE: Removal
See the complete sequence with detailed
steps on CDC’s website.
2. Goggles
or face
shield
3. Gown
4. Mask or
respirator
Source: Centers for Disease Control and Prevention. Sequence for donning and removing personal
protective equipment [poster online]. [cited 2014 May 23].
http://www.cdc.gov/HAI/pdfs/ppe/ppeposter1322.pdf
2014 ECRI Institute
38
PPE: Removal
 Remove before leaving patient room/ or work area.
 Place in designated area or container.
 Perform hand hygiene immediately or as soon as feasible after
removal.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
39
Limitations of Controls
Engineering controls,
work-practice controls,
labeling, and PPE can
help reduce the risk of
exposure to bloodborne
pathogens.
But they do not
eliminate the risk.
What can you do?
 Understand the risks.
 Vaccinate against HBV.
 Use standard precautions.
 Use controls properly.
 Report hazards and
incidents promptly.
 Give feedback.
2014 ECRI Institute
40
What to Do in an Event Involving Blood or
OPIM Exposure
Wash wounds, exposed
skin with soap and water.
Flush mucous
membranes.
Immediately notify your
supervisor and go to the
ED (and fill out employee
incident report)
Report right away!
Postexposure prophylaxis for HIV, if indicated,
should be started “as soon as possible,
preferably within hours of exposure.”
Sources: Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the
management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure
prophylaxis. MMWR Recomm Rep 2001 Jun 29;50(RR-11):1-52. Also available at
http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf; Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public
Health Service guidelines for the management of occupational exposures to human immunodeficiency virus
and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 2013 Sep;34(9):875-92.
Also available at http://www.jstor.org/stable/10.1086/672271
2014 ECRI Institute
41
Report an Exposure Incident
 Postexposure evaluation and follow-up will be done.
All medical
• at no cost to you
evaluations,
procedures, and • available at a reasonable time and place
• performed by or under the supervision of
postexposure
a licensed healthcare professional
prophylaxis will be
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
42
Postexposure Evaluation: What It Involves
Documentation of
exposure route,
circumstances
Postexposure prophylaxis
for HIV and/or HBV (if
indicated and accepted)
Identification of source
person (unless infeasible
or prohibited by law)
• Testing of source’s blood (if
consent obtained or if permitted
by law)
Counseling
Testing of your blood (with
your consent) for HBV and
HIV serologic status
Evaluation of reported
illnesses
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute
43
Postexposure Evaluation: Documentation
Depending on the circumstances, information about the exposure incident and resulting

illnesses may be recorded in our
OSHA
300 log
and
Sharps
injury log
Information about postexposure examinations, medical testing, and
follow-up procedures will be placed in your
Employee
medical
record
All have measures to protect your confidentiality.
Source: Occupational Safety and Health Administration. Bloodborne pathogens [standard online]. 29 CFR §
1910.1030. 2012 Apr 3 [cited 2014 May 14].
https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_id=10051&p_table=STANDARDS
2014 ECRI Institute